Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2b
- 31 October 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (10) , 1627-1635
- https://doi.org/10.1016/s0149-2918(02)80065-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cytokines and Cell Surface Receptors as Target End Points of Immunosuppression with Cyclosporine AJournal of Interferon & Cytokine Research, 2001
- Epidemiology of hepatitis CHepatology, 1997
- Hepatitis C: The clinical spectrum of diseaseHepatology, 1997
- Peripancreatic lymphoadenopathy and extrahepatic immunological manifestations in chronic hepatitis CEuropean Journal of Clinical Investigation, 1996
- Positive and negative immunomodulation by opioid peptidesInternational Journal of Immunopharmacology, 1996
- Prediction of response to interferon treatment of chronic hepatitis CJournal of Hepatology, 1994
- The intraportal lymphoid nodule and its environment in chronic active hepatitis C: An immunohistochemical studyHepatology, 1993
- Neuroendocrine Peptide Receptors on Cells of the Immune SystemPublished by S. Karger AG ,1992
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981
- Immunologic dysfunction in heroin addictsArchives of internal medicine (1960), 1974